Your search returned 2 results.

Results
	1.	The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. [electronic resource] by Holmström, M O Hjortsø, M D Ahmad, S M Met, Ö Martinenaite, E Riley, C Straten, P Svane, I M Hasselbalch, H C Andersen, M H Producer: 20170925 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy. [electronic resource] by Holmström, M O Martinenaite, E Ahmad, S M Met, Ö Friese, C Kjær, L Riley, C H Thor Straten, P Svane, I M Hasselbalch, H C Andersen, M H Producer: 20190102 In: Leukemia vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search